arznei-telegramm® 05/2017 |
SPOT ON |
Artificial shortage … unscrupulous price increase for off-patent cancer and other drugs |
NEW ON THE MARKET |
Nabilone (CANEMES) for chemotherapy-induced emesis and vomiting | FIASP: bizarre fruit of evergreening |
THERAPY FROM A CRITICAL VIEWPOINT |
Long-term data on adjuvant trastuzumab in breast cancer |
Breast cancer: Scalp cooling for the prevention of chemotherapy-induced alopecia |
IN BRIEF |
No benefit of levothyroxine (EUTHYROX, generics) for subclinical hypothyreosis in older adults |
CURRENT ADR NETWORK REPORT |
Once again – multiple vertebral fractures following stop of treatment with denosumab |
SIDE EFFECTS |
Improved blood glucose levels with hepatitis C treatment in patients with diabetes |
e a-t ON THE INTERNET – IN BRIEF |
Re-registration overdue for more than 25 years for five drugs |
e a-t ON THE INTERNET – SIDE EFFECTS |
Dupuytren contracture with vemuafenib (ZELBORAF) … an unwritten dear doctor letter |